About Teaching Hospital Motol, Oncology Clinic
Clinical Trials at Teaching Hospital Motol, Oncology Clinic
During the past decade, Teaching Hospital Motol, Oncology Clinic conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Teaching Hospital Motol, Oncology Clinic
According to Clinical.Site data, the most researched conditions in "Teaching Hospital Motol, Oncology Clinic" are
"Lung Diseases, Interstitial" (2 trials). Many other conditions were trialed in "Teaching Hospital Motol, Oncology Clinic" in a lesser frequency.
Clinical Trials Intervention Types at Teaching Hospital Motol, Oncology Clinic
Most popular intervention types in "Teaching Hospital Motol, Oncology Clinic" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Nintedanib" (1 trials), "Nintedanib (Ofev®)" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Teaching Hospital Motol, Oncology Clinic
The vast majority of trials in "Teaching Hospital Motol, Oncology Clinic" are
2 trials for "All" genders.
Clinical Trials Status at Teaching Hospital Motol, Oncology Clinic
Currently, there are NaN active trials in "Teaching Hospital Motol, Oncology Clinic".
undefined are not yet recruiting,
1 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Teaching Hospital Motol, Oncology Clinic,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Teaching Hospital Motol, Oncology Clinic, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".